Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells

NCT02549625 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Congenital Heart Disease

Interventions

BIOLOGICAL: Autologous Bone Marrow-derived Mononuclear Cells

Sponsor

Timothy J Nelson, MD, PhD

Collaborators

[object Object]